Nuclear Medicine

Nuclear medicine stands at the forefront of modern diagnostics and therapy, offering a unique glimpse into the very heart of cellular function and disease processes. It is a fascinating intersection of physics, chemistry, and medicine, using advanced technologies to diagnose, evaluate, and treat a variety of conditions, with a particular emphasis on cancer care.

Our department is equipped with cutting-edge modalities that represent the pinnacle of precision and innovation in medical imaging and therapy. Our facility houses two Siemens Biograph Horizon 16-Slice Time of Flight PET/CT systems, a Siemens Intevo Excel SPECT/CT system and a Perfint Maxio Lite PET/CT-guided Robotic biopsy arm.

Our diagnostic arsenal along with therapeutics with radiopharmaceuticals such as beta-emitters (Lutetium-177), alpha-emitters (Actinium-225), and low-dose iodine therapy are beacons of hope for our patients, illuminating paths to accurate diagnoses and effective treatments.

The gamma camera/SPECT CT is a marvel of medical imaging, offering a window into the body's inner workings. By detecting gamma rays emitted from radioactive tracers administered to the patient, it provides essential information about the function and structure of various organs and tissues. SPECT CT combines the functional imaging prowess of Single Photon Emission Computed Tomography (SPECT) with the detailed anatomical information provided by CT scans allowing for a more precise localization and characterization of abnormalities.

PET CT takes diagnostic imaging a step further, employing Positron Emission Tomography (PET) alongside CT to offer unparalleled insights into the body's metabolic activities. By highlighting areas of increased metabolism, PET CT can detect cancer at its earliest stages, often before it becomes visible on other imaging modalities. This synergy of functional and anatomical imaging is instrumental in planning the most effective treatment strategies. Along with Fluorine-18 based radiotracers like FDG for glucose metabolism imaging and NaF for bone scans, we perform some of the highest number of PET/CT scans with Gallium-68 based radiopharmaceuticals such as DOTATATE/DOTATOC for neuroendocrine tumors, PSMA for prostate cancer, and Exendin for pancreatic conditions, providing focused diagnosis catering to the specific and individualized requirements of each patient's disease.

Theranostics represents a revolutionary approach in nuclear medicine, merging diagnosis and therapy into a seamless, personalized treatment paradigm. Utilizing radiopharmaceuticals like Lutetium-177, Actinium-225, and Iodine-131, we can target cancer cells with remarkable precision, minimizing damage to surrounding healthy tissues. These targeted therapies are changing the landscape of cancer treatment, offering new hope to patients with previously intractable conditions.

Furthermore, our pioneering use of PET-CT guided robotic arm biopsy showcases our commitment to precision and patient safety, enabling us to precisely target active areas of lesions for biopsy with minimal complications, thereby enhancing diagnostic accuracy and optimizing patient outcomes.

Driven by ongoing research, technological advancements and with a deep understanding of disease processes, we ensure that we offer our patients access to the latest and most effective diagnostic and therapeutic options.